Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.

Di Costanzo A, Angelico R.

Molecules. 2019 Jun 7;24(11). pii: E2155. doi: 10.3390/molecules24112155. Review.

2.

Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.

Soleimani V, Delghandi PS, Moallem SA, Karimi G.

Phytother Res. 2019 Jun;33(6):1627-1638. doi: 10.1002/ptr.6361. Epub 2019 May 8. Review.

PMID:
31069872
3.

Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease.

Guo H, Cao H, Cui X, Zheng W, Wang S, Yu J, Chen Z.

Molecules. 2019 May 6;24(9). pii: E1748. doi: 10.3390/molecules24091748. Review.

4.

Effects of silymarin supplementation on blood lipids: A systematic review and meta-analysis of clinical trials.

Mohammadi H, Hadi A, Arab A, Moradi S, Rouhani MH.

Phytother Res. 2019 Apr;33(4):871-880. doi: 10.1002/ptr.6287. Epub 2019 Mar 5.

PMID:
30834633
5.

Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials.

Tao L, Qu X, Zhang Y, Song Y, Zhang SX.

Can J Gastroenterol Hepatol. 2019 Jan 10;2019:3192351. doi: 10.1155/2019/3192351. eCollection 2019. Review.

6.

Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.

Fogacci F, Grassi D, Rizzo M, Cicero AFG.

Phytother Res. 2019 Apr;33(4):862-870. doi: 10.1002/ptr.6282. Epub 2019 Jan 10. Review.

7.

A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties.

Romanucci V, Di Fabio G, Zarrelli A.

Molecules. 2018 Dec 29;24(1). pii: E108. doi: 10.3390/molecules24010108. Review.

8.

The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.

Hadi A, Pourmasoumi M, Mohammadi H, Symonds M, Miraghajani M.

Complement Ther Med. 2018 Dec;41:311-319. doi: 10.1016/j.ctim.2018.08.010. Epub 2018 Sep 3.

PMID:
30477860
9.

Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator.

Jahanafrooz Z, Motamed N, Rinner B, Mokhtarzadeh A, Baradaran B.

Life Sci. 2018 Nov 15;213:236-247. doi: 10.1016/j.lfs.2018.10.009. Epub 2018 Oct 9. Review.

PMID:
30308184
10.

Silimarin and Cancer.

Liakopoulou C, Kazazis C, Vallianou NG.

Anticancer Agents Med Chem. 2018;18(14):1970-1974. doi: 10.2174/1871520618666180905154949. Review.

PMID:
30205806
11.

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.

Cicero AFG, Colletti A, Bellentani S.

Nutrients. 2018 Aug 23;10(9). pii: E1153. doi: 10.3390/nu10091153.

12.

Review of Common Alternative Herbal "Remedies" for Skin Cancer.

Li JY, Kampp JT.

Dermatol Surg. 2019 Jan;45(1):58-67. doi: 10.1097/DSS.0000000000001622. Review.

PMID:
30096105
13.

Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.

Abenavoli L, Izzo AA, Milić N, Cicala C, Santini A, Capasso R.

Phytother Res. 2018 Nov;32(11):2202-2213. doi: 10.1002/ptr.6171. Epub 2018 Aug 6. Review.

PMID:
30080294
14.

Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.

Tajmohammadi A, Razavi BM, Hosseinzadeh H.

Phytother Res. 2018 Oct;32(10):1933-1949. doi: 10.1002/ptr.6153. Epub 2018 Jul 17. Review.

PMID:
30015401
15.

Role of silibinin in the management of diabetes mellitus and its complications.

Chu C, Li D, Zhang S, Ikejima T, Jia Y, Wang D, Xu F.

Arch Pharm Res. 2018 Aug;41(8):785-796. doi: 10.1007/s12272-018-1047-x. Epub 2018 Jul 6. Review.

PMID:
29978427
16.

Effects of silymarin on metabolic syndrome: a review.

Vahabzadeh M, Amiri N, Karimi G.

J Sci Food Agric. 2018 Oct;98(13):4816-4823. doi: 10.1002/jsfa.9115. Epub 2018 Jun 27. Review.

PMID:
29736939
17.

Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis.

Sridharan K, Sivaramakrishnan G.

Expert Rev Clin Pharmacol. 2018 Jun;11(6):641-650. doi: 10.1080/17512433.2018.1473760. Epub 2018 May 18. Review.

PMID:
29727586
18.

Management of Amanita phalloides poisoning: A literature review and update.

Ye Y, Liu Z.

J Crit Care. 2018 Aug;46:17-22. doi: 10.1016/j.jcrc.2018.03.028. Epub 2018 Mar 28. Review.

PMID:
29627659
19.

Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases.

Taleb A, Ahmad KA, Ihsan AU, Qu J, Lin N, Hezam K, Koju N, Hui L, Qilong D.

Biomed Pharmacother. 2018 Jun;102:689-698. doi: 10.1016/j.biopha.2018.03.140. Epub 2018 Apr 5. Review.

PMID:
29604588
20.

Silymarin: An interesting modality in dermatological therapeutics.

Dorjay K, Arif T, Adil M.

Indian J Dermatol Venereol Leprol. 2018;84(2):238-243. doi: 10.4103/ijdvl.IJDVL_746_16. Review. No abstract available.

Supplemental Content

Loading ...
Support Center